DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Port Charlotte, FL

7 verified pulmonary disease doctors in Port Charlotte.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Florida Board of Medicine

Dr. Thongadi Chandrahasa, MD

Pulmonary Disease

21 yrs NPPES
NPI 1992786594
3400 TAMIAMI TRL, SUITE 201, Port Charlotte, FL 33952(941) 743-2277
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Carlos Maas, MD

Pulmonary Disease

20 yrs NPPES
NPI 1710957907
4235 KINGS HWY, SUITE 103, Port Charlotte, FL 33980(941) 613-1777
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,507 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,507

Total received

121

Transactions

19

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$556.62
GlaxoSmithKline, LLC.$452.29
Takeda Pharmaceuticals U.S.A., Inc.$446.74
Actelion Pharmaceuticals US, Inc.$434.98
Insmed, Inc.$102.30
Grifols USA, LLC$82.41

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Carlos Maas do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Saligrama Bhat, MD

Pulmonary Disease

20 yrs NPPES
NPI 1639129182
3410 TAMIAMI TRAIL, SUITE 2, Port Charlotte, FL 33952(941) 629-8006
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $552.16 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$552.16

Total received

36

Transactions

8

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$271.88
AstraZeneca Pharmaceuticals LP$132.49
Inogen, Inc.$49.23
Genentech USA, Inc.$25.02
Pfizer Inc.$21.90
Mylan Specialty L.P.$21.07

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 74th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Saligrama Bhat do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jaime Cancel, MD

Pulmonary Disease

20 yrs NPPES
NPI 1689778706
4235 KINGS HIGHWAY, SUITE 103, Port Charlotte, FL 33980(941) 613-1777
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,960 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,960

Total received

153

Transactions

16

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$572.11
Takeda Pharmaceuticals U.S.A., Inc.$522.50
AstraZeneca Pharmaceuticals LP$503.34
Actelion Pharmaceuticals US, Inc.$214.54
Regeneron Healthcare Solutions, Inc.$173.19
Grifols USA, LLC$170.05

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 89th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jaime Cancel do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Rajeshri Patel, MD

Pulmonary Disease

20 yrs NPPES
NPI 1366503344
3014 TAMIAMI TRL, Port Charlotte, FL 33952(941) 625-7775
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,204 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,204

Total received

47

Transactions

18

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$165.58
GlaxoSmithKline, LLC.$165.56
Regeneron Healthcare Solutions, Inc.$158.00
United Therapeutics Corporation$153.08
AstraZeneca Pharmaceuticals LP$128.19
Inspire Medical Systems, Inc.$109.85

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Rajeshri Patel do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Edgardo Soto De La Rosa, MD

Pulmonary Disease

17 yrs NPPES
NPI 1801030408
4235 KINGS HWY, SUITE 103, Port Charlotte, FL 33980(941) 613-1777
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,868 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,868

Total received

101

Transactions

19

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$604.99
AstraZeneca Pharmaceuticals LP$385.72
Mylan Specialty L.P.$148.87
Regeneron Healthcare Solutions, Inc.$131.80
Grifols USA, LLC$82.80
Insmed, Inc.$54.08

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Edgardo Soto De La Rosa do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Lohaliz Bobe, MD

Pulmonary Disease

17 yrs NPPES
NPI 1851528202
4235 KINGS HWY, SUITE 103, Port Charlotte, FL 33980(941) 613-1777
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $3,650 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,650

Total received

187

Transactions

25

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$746.02
AstraZeneca Pharmaceuticals LP$651.41
Takeda Pharmaceuticals U.S.A., Inc.$584.25
Actelion Pharmaceuticals US, Inc.$393.61
Grifols USA, LLC$189.42
Bayer HealthCare Pharmaceuticals Inc.$151.68

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Lohaliz Bobe do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Port Charlotte, FL — Verified | DoctorsProof | DoctorsProof